FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307776247> ?p ?o ?g. }

• W4307776247 endingPage "1267" @default.
• W4307776247 startingPage "1267" @default.
• W4307776247 abstract "Importance It is currently unknown how often and in which ways a genetic diagnosis given to a patient with epilepsy is associated with clinical management and outcomes. Objective To evaluate how genetic diagnoses in patients with epilepsy are associated with clinical management and outcomes. Design, Setting, and Participants This was a retrospective cross-sectional study of patients referred for multigene panel testing between March 18, 2016, and August 3, 2020, with outcomes reported between May and November 2020. The study setting included a commercial genetic testing laboratory and multicenter clinical practices. Patients with epilepsy, regardless of sociodemographic features, who received a pathogenic/likely pathogenic (P/LP) variant were included in the study. Case report forms were completed by all health care professionals. Exposures Genetic test results. Main Outcomes and Measures Clinical management changes after a genetic diagnosis (ie, 1 P/LP variant in autosomal dominant and X-linked diseases; 2 P/LP variants in autosomal recessive diseases) and subsequent patient outcomes as reported by health care professionals on case report forms. Results Among 418 patients, median (IQR) age at the time of testing was 4 (1-10) years, with an age range of 0 to 52 years, and 53.8% (n = 225) were female individuals. The mean (SD) time from a genetic test order to case report form completion was 595 (368) days (range, 27-1673 days). A genetic diagnosis was associated with changes in clinical management for 208 patients (49.8%) and usually (81.7% of the time) within 3 months of receiving the result. The most common clinical management changes were the addition of a new medication (78 [21.7%]), the initiation of medication (51 [14.2%]), the referral of a patient to a specialist (48 [13.4%]), vigilance for subclinical or extraneurological disease features (46 [12.8%]), and the cessation of a medication (42 [11.7%]). Among 167 patients with follow-up clinical information available (mean [SD] time, 584 [365] days), 125 (74.9%) reported positive outcomes, 108 (64.7%) reported reduction or elimination of seizures, 37 (22.2%) had decreases in the severity of other clinical signs, and 11 (6.6%) had reduced medication adverse effects. A few patients reported worsening of outcomes, including a decline in their condition (20 [12.0%]), increased seizure frequency (6 [3.6%]), and adverse medication effects (3 [1.8%]). No clinical management changes were reported for 178 patients (42.6%). Conclusions and Relevance Results of this cross-sectional study suggest that genetic testing of individuals with epilepsy may be materially associated with clinical decision-making and improved patient outcomes." @default.
• W4307776247 created "2022-11-05" @default.
• W4307776247 creator A5001910056 @default.
• W4307776247 creator A5005038980 @default.
• W4307776247 creator A5005271094 @default.
• W4307776247 creator A5006035858 @default.
• W4307776247 creator A5006719625 @default.
• W4307776247 creator A5006753163 @default.
• W4307776247 creator A5007477990 @default.
• W4307776247 creator A5009697736 @default.
• W4307776247 creator A5010794783 @default.
• W4307776247 creator A5010880834 @default.
• W4307776247 creator A5010950756 @default.
• W4307776247 creator A5010996295 @default.
• W4307776247 creator A5012651735 @default.
• W4307776247 creator A5013206120 @default.
• W4307776247 creator A5013507976 @default.
• W4307776247 creator A5013570044 @default.
• W4307776247 creator A5013782204 @default.
• W4307776247 creator A5013860280 @default.
• W4307776247 creator A5014829476 @default.
• W4307776247 creator A5015251962 @default.
• W4307776247 creator A5015437955 @default.
• W4307776247 creator A5015847011 @default.
• W4307776247 creator A5016637079 @default.
• W4307776247 creator A5016838653 @default.
• W4307776247 creator A5017218150 @default.
• W4307776247 creator A5017377518 @default.
• W4307776247 creator A5018067889 @default.
• W4307776247 creator A5018116837 @default.
• W4307776247 creator A5019560716 @default.
• W4307776247 creator A5019635231 @default.
• W4307776247 creator A5019883609 @default.
• W4307776247 creator A5020392974 @default.
• W4307776247 creator A5020844442 @default.
• W4307776247 creator A5021733466 @default.
• W4307776247 creator A5022075918 @default.
• W4307776247 creator A5022224897 @default.
• W4307776247 creator A5022448748 @default.
• W4307776247 creator A5022804691 @default.
• W4307776247 creator A5023124967 @default.
• W4307776247 creator A5023966250 @default.
• W4307776247 creator A5024023103 @default.
• W4307776247 creator A5025324200 @default.
• W4307776247 creator A5026053959 @default.
• W4307776247 creator A5027472067 @default.
• W4307776247 creator A5028320828 @default.
• W4307776247 creator A5028804707 @default.
• W4307776247 creator A5029407224 @default.
• W4307776247 creator A5029520466 @default.
• W4307776247 creator A5030509932 @default.
• W4307776247 creator A5030755658 @default.
• W4307776247 creator A5031663349 @default.
• W4307776247 creator A5031940023 @default.
• W4307776247 creator A5031983656 @default.
• W4307776247 creator A5032129336 @default.
• W4307776247 creator A5032204634 @default.
• W4307776247 creator A5033728543 @default.
• W4307776247 creator A5034448513 @default.
• W4307776247 creator A5035713088 @default.
• W4307776247 creator A5036279435 @default.
• W4307776247 creator A5039636417 @default.
• W4307776247 creator A5040691205 @default.
• W4307776247 creator A5040925453 @default.
• W4307776247 creator A5041170608 @default.
• W4307776247 creator A5042266346 @default.
• W4307776247 creator A5042755402 @default.
• W4307776247 creator A5043692984 @default.
• W4307776247 creator A5044887457 @default.
• W4307776247 creator A5045461985 @default.
• W4307776247 creator A5045532526 @default.
• W4307776247 creator A5046186356 @default.
• W4307776247 creator A5047671959 @default.
• W4307776247 creator A5048526183 @default.
• W4307776247 creator A5049479938 @default.
• W4307776247 creator A5049728756 @default.
• W4307776247 creator A5052055830 @default.
• W4307776247 creator A5052808356 @default.
• W4307776247 creator A5053054031 @default.
• W4307776247 creator A5054025577 @default.
• W4307776247 creator A5055955550 @default.
• W4307776247 creator A5056228189 @default.
• W4307776247 creator A5056695807 @default.
• W4307776247 creator A5060851210 @default.
• W4307776247 creator A5061340831 @default.
• W4307776247 creator A5061465420 @default.
• W4307776247 creator A5061544190 @default.
• W4307776247 creator A5062719635 @default.
• W4307776247 creator A5062861420 @default.
• W4307776247 creator A5062886170 @default.
• W4307776247 creator A5063025626 @default.
• W4307776247 creator A5063084694 @default.
• W4307776247 creator A5063196753 @default.
• W4307776247 creator A5063358391 @default.
• W4307776247 creator A5063644797 @default.
• W4307776247 creator A5063718763 @default.
• W4307776247 creator A5063722456 @default.
• W4307776247 creator A5063919343 @default.

• next